COMP <GO>
RVTY vs UNH // NET PROFIT MARGIN
Revvity Inc. (NYSE) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: RVTY 5
— UNH 7
▲ NET PROFIT MARGIN LEADER: RVTY
LAST: $163.48 (+7.84%) • MKT CAP: $16.92B
net-margins
8.40%
LAST: $404.44 (+1.00%) • MKT CAP: $359.43B
net-margins
3.53%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (RVTY VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | RVTY | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 88.31% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 3.10% | 12.38% | -9.28 | UNH | /roic <GO> |
| EV/EBITDA & P/E Valuation | 48.2x | 15.3x | +32.93 | UNH | /valuation <GO> |
| Free Cash Flow Yield | 2.75% | 6.25% | -3.50 | UNH | /fcf-yield <GO> |
| Operating Margin | 12.50% | 5.32% | +7.18 | RVTY | /operating-margins <GO> |
| Net Profit Margin ACTIVE | 8.40% | 3.53% | +4.87 | RVTY | /net-margins <GO> |
| Revenue Growth (YoY) | 3.70% | 3.33% | +0.37 | RVTY | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.18% | 2.29% | -2.11 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.37 | 3.09 | +0.28 | RVTY | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 7.00% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 45.9 | 55.1 | -9.20 | UNH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.95 | 0.33 | +0.62 | RVTY | /macro-sensitivity <GO> |
| Forward P/E Multiple | 71.3x | 17.7x | +53.56 | UNH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $16.92B | $359.43B | -$342.52B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | RVTY REV | UNH REV | RVTY GROSS % | UNH GROSS % | RVTY FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.86B | $447.57B | — | 88.7% | $509.4M | $16.07B |
| FY 2024 | $2.76B | $400.28B | — | 88.3% | $541.7M | $20.70B |
| FY 2023 | $2.75B | $371.62B | — | 89.6% | -$32.5M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
RVTY // BETA 0.95
UNH // BETA 0.33